Fox Host Debunks Trump's 600% Drug Price Cut Claim
A Fox News anchor delivered a brutal math lesson on air, highlighting the impossibility of Trump's claim about slashing prescription drug prices by 600%. See the reality vs. perception clash unfold.
Category : Search result: pharmaceutical licensing
Health Canada Approves Drug for Rare Disease
Health Canada has granted approval for a new pharmaceutical treatment targeting a rare disease, offering hope for patients. Learn about the regulatory decision and its impact.
Pfizer 2026 profit forecast below expectations
Pfizer projects 2026 profits below Wall Street estimates due to a steep drop in COVID product sales and loss of exclusivity for key drugs. Get the full business analysis.
China's Biopharma Surge Challenges Global Drug Leaders
China's biopharma industry is accelerating, fueled by record investment and streamlined supply chains. With faster development times and massive deals like AstraZeneca's $5.2B pact, the global drug innovation race is heating up. Discover the shift from ou
Eli Lilly cuts price of obesity drug Zepbound
Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.
Boehringer Ingelheim Names New Board Member for IT
Boehringer Ingelheim announces Harsha Deshmukh's appointment to Board of Managing Directors for IT and Global Business Services effective February 2026.
Grey Bruce drug disposal nets meds for hockey tickets
Grey Bruce residents exchanged unused pharmaceuticals for Barrie Colts hockey tickets in a successful medication safety initiative. Learn how this program helps combat opioid misuse and environmental contamination.
Dipharma's Novel Method Detects Nitrosamine Risks
Dipharma publishes a peer-reviewed study unveiling a novel method to detect and characterize nitrosamine impurities in Active Pharmaceutical Ingredients, enhancing drug safety and regulatory compliance.
Novo Nordisk Alzheimer's Drug Trials Fail
Danish pharmaceutical giant Novo Nordisk faces major setback as Alzheimer's drug trials fail. Learn how this impacts the weight-loss leader's expansion plans.
India probes cough syrup deaths amid safety concerns
Indian officials are investigating whether safety failures led to children dying from contaminated cough syrup. Get the latest details on this developing health crisis.
Eli Lilly Reaches $1 Trillion Valuation Milestone
Eli Lilly becomes the first pharmaceutical company to achieve a US$1 trillion market valuation, driven by unprecedented demand for its weight-loss treatments. Discover how this milestone reshapes the industry.
Denmark compensates for Novo Nordisk vision loss
Danish authorities provide compensation to patients experiencing vision loss linked to Novo Nordisk medications. Learn about the pharmaceutical safety developments affecting Canadian consumers.
Teva Launches Global Innovation Platform for Pharma Breakthroughs
Teva Pharmaceutical launches Rise, a global open innovation platform connecting startups with pharma challenges in AI, digital health and smart manufacturing to accelerate patient impact.
Journal sued over controversial antidepressant drug trial
A medical journal faces legal action after publishing a study promoting antidepressant use for youth depression treatment. The infamous drug trial returns to spotlight amid growing concerns.
Fake Viagra Sold at Toronto Store: Health Canada
Health Canada warns about counterfeit Viagra discovered at a Toronto convenience store. Learn how to identify fake medications and protect your health.
Windsor Changes Dog Licensing Fees System
Windsor announces new dog licensing fee structure focusing on problem owners while maintaining fairness for responsible pet owners. Learn about the changes.
How to Safely Dispose of Expired Medications
Learn the correct methods for disposing expired or unused medications in Canada. Protect your family and environment with proper drug disposal practices.
Novo Nordisk rolls out $349 Wegovy cash price early
Novo Nordisk introduces $349 cash price for Wegovy weight-loss drug ahead of schedule. Learn how this affects Canadian healthcare access and affordability.
J&J buys Halda Therapeutics for $3.05 billion
Johnson & Johnson expands its oncology portfolio with $3.05 billion acquisition of Halda Therapeutics, strengthening its cancer treatment pipeline. Learn about this major healthcare investment.
Canadian Creatives Target Licensing for AI 'Slop' Problem
As AI-generated content floods digital spaces, Canada's creative industry pushes for new licensing framework to protect original work and ensure fair compensation.
400 Quebec doctors apply to leave after health bill
Nearly 400 Quebec physicians have applied to practice elsewhere in Canada following the controversial Bill 2, marking a significant departure from historical trends. Read more about the healthcare exodus.
Barbados Launches US$200M Life Sciences Hub
Barbados partners with EarlyHealth Group to build a US$200 million life sciences hub, positioning the island as the Caribbean's premier pharmaceutical and research centre.
Pfizer wins $10B obesity drug takeover battle
Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.
Trump's Plan to Slash Obesity Drug Prices
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.
Trump's Drug Price Plan Backfires, Helps Democrats
Former President Trump's proposal to regulate Medicare drug prices faces unexpected consequences as Democrats leverage it to attack Republican positions on healthcare, creating political turmoil.
Trump Reveals Deal to Lower Obesity Drug Costs
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giant to make obesity drugs more affordable and accessible across the United States.
Trump Obesity Drug Deal Boosts Pharma Stocks
Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.
Essex Waives Taxi Licensing Fees Until 2025
The Town of Essex eliminates taxi licensing fees until December 2025, providing financial relief for drivers and improving transportation access for residents across the municipality.
Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board
Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.
Ottawa's Solution to Doctor Shortage Crisis
Discover how Ottawa is implementing innovative solutions to tackle the critical physician shortage, from international recruitment to streamlined licensing processes that could become a national model.
Page 1 of 2